Poor sleep in multiple sclerosis correlates with Beck Depression Inventory values, but not with polysomnographic data by Veauthier, C. et al.
Research Article
Poor Sleep in Multiple Sclerosis Correlates with Beck Depression
Inventory Values, but Not with Polysomnographic Data
Christian Veauthier,1 Gunnar Gaede,2,3 Helena Radbruch,2
Klaus-Dieter Wernecke,4 and Friedemann Paul2,5,6
1 Interdisciplinary Center of Sleep Medicine, Charite´ University Medicine Berlin, Charite´platz 1, 10117 Berlin, Germany
2NeuroCure Clinical Research Center, Charite´ University Medicine Berlin, Charite´platz 1, 10117 Berlin, Germany
3Department of Neurology, St. Joseph Hospital Berlin-Weissensee, 13088 Berlin, Germany
4CRO SOSTANA GmbH and Charite´ University Medicine Berlin, Wildensteiner Straße 27, 10318 Berlin, Germany
5Clinical and Experimental Multiple Sclerosis Research Center, Department of Neurology, Charite´ University Medicine Berlin,
10117 Berlin, Germany
6Experimental and Clinical Research Center, Max Delbru¨ck Center for Molecular Medicine and Charite´ University Medicine Berlin,
13125 Berlin, Germany
Correspondence should be addressed to Christian Veauthier; cveauthier@web.de
Received 26 September 2015; Revised 20 December 2015; Accepted 22 December 2015
Academic Editor: Luigi Ferini-Strambi
Copyright © 2016 Christian Veauthier et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Objectives. Pittsburgh Sleep Quality Index (PSQI) values correlate with depression, but studies investigating the relationship
between PSQI values and polysomnographic (PSG) data showed inconsistent findings. Methods. Sixty-five consecutive patients
with multiple sclerosis (MS) were retrospectively classified as “good sleepers” (GS) (PSQI ≤ 5) and “poor sleepers” (PS) (PSQI > 5).
The PSG data and the values of the Visual Analog Scale (VAS) of fatigue, Modified Fatigue Impact Scale (MFIS), Fatigue Severity
Scale (FSS), Epworth Sleepiness Scale (ESS), and the Beck Depression Inventory (BDI) were compared. Results. No significant
differences were found either for PSG data or for ESS, MFIS, and FSS values; but PS showed significantly increased BDI and VAS
values. Conclusions. Poor sleep is associated with increased depression and fatigue scale values.
1. Introduction
In several studies Pittsburgh Sleep Quality Index (PSQI)
values [1] correlated with sleep diary variables and depression
scales [2, 3], but not with actigraphic and polysomnographic
(PSG) data [4–7].
The PSQI is a self-rated questionnaire, which assesses
sleep quality and disturbances by seven component scores
(subjective sleep quality, sleep latency, sleep duration, habit-
ual sleep efficiency, sleep disturbances, use of sleeping med-
ication, and daytime dysfunction). Good sleepers (GS) show
PSQI values ≤ 5 whereas poor sleepers (PS) are defined by
values > 5.
Poor sleep measured with the PSQI correlates with the
diagnostic criteria of insomnia of the Diagnostic and Sta-
tistical Manual of Mental Disorders (DSM) Fourth Edition
[8]. The PSQI is widely used as a screening instrument for
insomnia [9].
In contrast to insomnia OSA is normally not associated
with an increased sleep latency [10]. Macey et al. [7] did not
find any relationship between PSQI values and OSA in 49
patients. Veauthier [11] classified 231 untreated OSA patients,
102 treated OSA patients, 22 insomnia patients, and 19
patients with restless legs syndrome (RLS) or periodic limb
movement disorder (PLMD) in GS and PS.Whereas all inso-
mnia patients, the majority of RLS/PLMD patients, and most
untreated OSA patients were PS, almost half of the treated
OSA patients were PS. In this study, untreated OSA GS had
significantly more deep sleep compared with untreated OSA
PS. The discrepancy of these two studies [10, 11] could be
explained by the bigger sample size in the study by Veauthier
and by the different study design: Macey et al. investigated
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the linear relationship between PSQI values and AHI,
whereas Veauthier classified his patients into GS and PS and
then analyzed the differences between the two subgroups.
Manzar et al. [12] found a negative correlation between
sleep onset latency (SOL) and PSQI values in healthy stu-
dents. All other PSG data did not show any difference.
Sleep disorders are frequent in MS.The aim of this retro-
spective study was to classifyMS patients in GS and PS and to
investigate whether poor sleep is associated with depression
scores or with PSG data.
2. Methods
2.1. Participants. This is a retrospective analysis of the PSQI
values from a previously published study investigating MS
patients by home-based polysomnography (in the original
work, the PSQI values have not been published) [13]. In
the original study 66 MS patients (aged 20–66 years) were
included from whom 49 patients were suffering from sleep
disorders (OSA, 𝑛 = 8; insomnia, 𝑛 = 17; RLS/PLMD, 𝑛 =
24). For more demographic details and performance and
classification of the PSG please see the original article [13].
2.2. Measures and Procedures. In this retrospective data
analysis, the following values were obtained.
2.2.1. Polysomnographic Data. They include sleep efficiency
(SE) (sleep in percent of time in bed, %/TiB), SOL inminutes,
non-REM sleep 1 and non-REM sleep 2 (%/TiB), deep sleep
(%/TiB), REM sleep (%/TiB), arousal-index (per hour sleep,
/h), wake after sleep onset in minutes, number of sleep stage
changes per night, awakenings per night, and periodic limb
movement index (/h). Due to the small sample size of OSA
patients the AHI and further respiratory parameters were not
included in this analysis.
2.2.2. Questionnaires. The questionnaires include PSQI [1],
Visual Analog Scale (VAS) of fatigue scored 0–10 cm [14],
Modified Fatigue Impact Scale (MFIS) [15], Fatigue Severity
Scale (FSS) [14], Epworth Sleepiness Scale (ESS) [16], and the
Beck Depression Inventory (BDI) [17].
2.3. Statistical Analysis. Patients were classified according to
their PSQI values in GS (PSQI ≤ 5) and PS (PSQI > 5). Fol-
lowing an exploratory analysis of the data theMann-Whitney
U test for pairwise comparisons was performed. Statistical
significance was established at <0.05. Due to the exploratory
nature of the study, all tests were performed as exploratory
data analyses, such that no adjustments for multiple testing
have been made. Analysis was performed with SPSS software
(IBM SPSS Statistics, Version 21, Copyright 1989, 2010 SPSS
Inc., an IBM Company, Chicago, IL, USA).
3. Results
Table 1 displays the results. Forty-two patients were classified
into PS and 23 into GS (from one patient no PSQI data were
obtained). PSG data were not significantly different between
the two subgroups.
The comparison of the questionnaires showed significant
differences for the VAS of fatigue (PS: mean 5.6/SD ± 2.6; GS:
mean 3.0/SD ± 2.3; 𝑃 = 0.001) and BDI (PS: mean 12.9/SD ±
8.6; GS: mean 9.3/SD ± 8.2; 𝑃 = 0.049), whereas the other
questionnaires did not show any difference. In particular, the
MFIS values and FSS values were higher in PS compared to
GS but without statistical significance (mean MFIS values
40.9 versus 29.9; 𝑃 = 0.053/mean FSS-values 5.0 versus 4.1;
𝑃 = 0.184).
Twenty-nine patients (21 PS and 8 GS) were suffering
from excessive daytime sleepiness (EDS) (according to ESS
values ≥ 10). Although the ESS values were higher in PS, this
was not significant (PS:mean 9.6/SD+ 5.0; GS:mean 7.7/SD+
4.0; 𝑃 = 0.112) (see Table 1).
4. Discussion
PS showed increased depression and fatigue scores compared
to GS, whereas the PSG data were not significantly different
between the two subgroups. These findings are in line with
previous studies demonstrating a close relationship between
PSQI values and depression whereas no relationship with
PSG data could be found.
In insomnia, sleep disturbances are the key symptom of
the disorder and the PSQI shows a sensitivity of almost 100
percent for insomnia [9, 11]. The PSQI is a good diagnostic
screening tool for insomnia.
In the abovementioned study by Veauthier [11], however,
only 72 percent of untreated OSA patients were PS. OSA can
even be asymptomatic in moderate or severe OSA (high AHI
without subjective sleep disturbances). In summary, in MS
patients the PSQI alone without other questionnaires is not
a reliable screening tool for sleep disorders in general (e.g.,
OSA).
Although the PS showed higher mean ESS values com-
pared toGS, this difference was not significant.Themean ESS
values were higher in PS as well as in GS compared to the
ESS values of healthy controls in the literature [18]. Almost
half of PS were suffering from EDS and almost one-third of
GS. Sleep disorders were not significantly associated with ESS
values but with fatigue [13].Themost frequent sleep disorders
in the present study (insomnia, PLMD, and RLS) cause more
likely fatigue than sleepiness [19]. Moreover, sleepiness is
usually measured by multiple sleep latency tests (MSLT) and
several studies showed inconsistent findings between the
results of the ESS and the objective measurements by the
MSLT, meaning that the ESS and the MSLT do not measure
the same aspects of sleepiness [20]. In our study no MSLT
was performed; therefore, we cannot compare the BDI values
with objectivemeasurements of sleepiness. Beyond that, asso-
ciations between depressive symptoms and hypersomnia are
complex and often bidirectional [21]. Of the many disorders
associatedwith excessive sleepiness in the general population,
the most frequent are mental health disorders, particularly
depression [21].
The question remains, why PS show significantly inc-
reased BDI values. On the one hand, sleep disorders can lead
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Table 1: Demographic data and results of questionnaires and polysomnography.
All Poor sleepers Good sleepers 𝑃 values
𝑛 (w/m) 65 (44/21) 42 (29/13) 23 (15/8) 0.787
Age (years)
Mean ± SD 44.6 ± 10.0 46.4 ± 10.4 41.5 ± 8.7
0.05125% 39.8 40.8 32.0
75% 50.0 52.3 48.0
Disease duration
(years)
Mean ± SD 12.4 ± 9.0 13.4 ± 10.1 10.2 ± 6.3
0.56225% 5.0 5.0 4.8
75% 18.5 20.8 13.0
Sleep disorder
Insomnia 17 15 2
0.012OSA 8 5 3
PLMD/RLS 23 16 7
None 17 6 11
VAS
Mean ± SD 4.7 ± 2.7 5.6 ± 2.6 3.0 ± 2.3
0.00125% 2.8 4.2 1.1
75% 7.0 7.3 4.3
MFIS
Mean ± SD 37 ± 20.4 40.9 ± 18.3 29.9 ± 22.8
0.05325% 20.8 31.8 18.0
75% 53.0 53.8 52.0
PSQI
Mean ± SD 7.7 ± 4.2 10.0 ± 3.5 3.6 ± 1.4
<0.000125% 5.0 7.0 2.0
75% 11.0 13.0 5.0
ESS
Mean ± SD 8.9 ± 4.7 9.6 ± 5.0 7.7 ± 4.0
0.11225% 5.3 6.3 3.0
75% 13.0 14.0 10.0
BDI
Mean ± SD 11.7 ± 8.6 12.9 ± 8.6 9.3 ± 8.2
0.04925% 5.0 12.0 7.0
75% 17.3 18.3 12.0
FSS
Mean ± SD 4.6 ± 2.2 5.0 ± 2.3 4.1 ± 2.0
0.18425% 3.1 3.8 2.5
75% 6.4 6.4 6.0
Arousal-index (𝑛/h)
Mean ± SD 19.9 ± 10.3 19.7 ± 9.5 20.4 ± 11.8
0.88025% 13.7 13.8 10.2
75% 24.2 23.9 26.9
N1 and N2
(%/TiB)
Mean ± SD 51.2 ± 12.2 50.0 ± 3.7 53.7 ± 8.8
0.38025% 43.6 40.2 45.5
75% 62.5 62.6 62.0
N3
(%/TiB)
Mean ± SD 10.4 ± 6.4 10.6 ± 6.1 10.3 ± 7.0
0.70625% 5.4 5.7 5.1
75% 15.4 15.3 15.7
REM
(%/TiB)
Mean ± SD 14.3 ± 7.4 13.6 ± 7.3 15.5 ± 7.7
0.26625% 10.6 10.4 11.6
75% 17.5 17.0 20.4
Sleep efficacy
(%/TiB)
Mean ± SD 76.3 ± 12.3 74.9 ± 13.3 79.1 ± 10.3
0.30025% 68.7 63.6 75.6
75% 86.5 85.6 86.7
4 Sleep Disorders
Table 1: Continued.
All Poor sleepers Good sleepers 𝑃 values
WASO
(minutes)
Mean ± SD 83.8 ± 57.3 89.6 ± 62.5 76.44 ± 44.7
0.68625% 43.0 37.5 44.0
75% 120.0 132.8 104.0
Sleep onset latency
(minutes)
Mean ± SD 31.9 ± 35.7 36.2 ± 40.5 20.6 ± 15.6
0.05725% 12.5 15.5 9.0
75% 41.0 43.5 32.0
Sleep stage changes
(𝑛)
Mean ± SD 145.7 ± 47.4 148.8 ± 48.0 140.7 ± 47.8
0.49325% 119.0 120.5 106.0
75% 171.8 178.3 170.0
Awakenings (𝑛)
Mean ± SD 26.7 ± 12.4 27.8 ± 11.4 25.4 ± 13.8
0.18725% 18.0 20.5 18.0
75% 32.0 33.0 31.0
PLM-index
(𝑛/h)
Mean ± SD 23.0 ± 29.7 19.8 ± 24.2 27.2 ± 37.2
0.75725% 2.3 2.9 1.8
75% 35.7 32.8 38.8
PLM-arousal-index
(𝑛/h)
Mean ± SD 2.8 ± 4.2 2.5 ± 4.2 3.1 ± 4.3
0.69525% 0.2 0.2 0.2
75% 3.6 3.1 5.8
OSA: obstructive sleep apnea; PLMD: periodic limbmovement disorder; RLS: restless legs syndrome; VAS: Visual Analog Scale;MFIS:Modified Fatigue Impact
Scale; PSQI: Pittsburgh Sleep Quality Index; ESS: Epworth Sleepiness Scale; BDI: Beck Depression Inventory; FSS: Fatigue Severity Scale; TiB: time in bed; N1:
sleep stage NREM 1; N2: sleep stage NREM 2; N3: sleep stage NREM 3; REM: rapid eyemovement;WASO: wake after sleep onset; PLM: periodic legmovement.
to fatigue and there is an overlap between fatigue and depres-
sion [22]. Moreover, the prevalence of depression is increased
in patients suffering fromOSA or insomnia or RLS, and sleep
disorders and depression are interdependent and influence
each other [21, 23–25]. The fact that in the present study the
BDI values were increased in PS could be due to depression
itself or it might be the consequence of an underlying sleep
disorder. An overestimation of sleep problems is possible as
well: in the study by McCrae et al. [26] noncomplaining GS
had poorer objective sleep quantity than complaining PS.
Moreover, insomnia patients underestimate their SE whereas
healthy persons overestimate their SE [27]. However, MS
patients with increased BDI values (whether suffering from
clinically defined depression or not) tend to perceive their
sleep as disturbed and almost two-thirds of consecutive MS
patients report poor sleep quality in this study. This presents
a challenge for the treatment of MS patients and further
studies are needed in regard to this issue.
5. Limitations
This is a retrospective data analysis with a limited sample size;
further prospective studies are needed.
6. Conclusions
In this retrospective study of MS patients, PS showed increa-
sed depression and fatigue scale values compared to GS,
whereas PSGdata were not significantly different between the
two subgroups.
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